Latest News and Press Releases
Want to stay updated on the latest news?
-
CAMBRIDGE, Mass., March 20, 2007 (PRIME NEWSWIRE) -- Infinity Pharmaceuticals (Nasdaq:INFI) announced today that its Board of Directors unanimously voted to approve a corporate governance initiative...
-
CAMBRIDGE, Mass., Feb. 23, 2007 (PRIME NEWSWIRE) -- Infinity Pharmaceuticals, Inc. (Nasdaq:INFI), an innovative cancer drug discovery and development company, today announced that Adelene Q. Perkins,...
-
CAMBRIDGE, Mass. and GAITHERSBURG, Md., Feb. 14, 2007 (PRIME NEWSWIRE) -- Infinity Pharmaceuticals, Inc. (Nasdaq:INFI) and MedImmune, Inc. (Nasdaq:MEDI) today announced the initiation of a Phase I/II...
-
CAMBRIDGE, Mass., Feb. 7, 2007 (PRIME NEWSWIRE) -- Infinity Pharmaceuticals, Inc. (Nasdaq:INFI), an innovative cancer drug discovery and development company, today announced results for the quarter...
-
CAMBRIDGE, Mass., Feb. 6, 2007 (PRIME NEWSWIRE) -- Infinity Pharmaceuticals, Inc. (Nasdaq:INFI), an innovative cancer drug discovery and development company, today announced that executive management...
-
CAMBRIDGE, Mass., Feb. 1, 2007 (PRIME NEWSWIRE) -- Infinity Pharmaceuticals, Inc. (Nasdaq:INFI), an innovative cancer drug discovery and development company, today announced that Infinity management...
-
CAMBRIDGE, Mass., Jan. 26, 2007 (PRIME NEWSWIRE) -- Infinity Pharmaceuticals, Inc. (Nasdaq:INFI), an innovative cancer drug discovery and development company, yesterday was named the recipient of the...
-
ORLANDO, Fla., Jan. 22, 2007 (PRIME NEWSWIRE) -- Infinity Pharmaceuticals, Inc. (Nasdaq:INFI) and MedImmune, Inc. (Nasdaq:MEDI) today announced updated preliminary data from an open-label Phase I...
-
CAMBRIDGE, Mass., Jan. 8, 2007 (PRIME NEWSWIRE) -- Infinity Pharmaceuticals, Inc. (Nasdaq:INFI), an innovative cancer drug discovery and development company, today announced its product and business...
-
CAMBRIDGE, Mass., Jan. 4, 2007 (PRIME NEWSWIRE) -- Infinity Pharmaceuticals, Inc. (Nasdaq:INFI), today announced that the company's presentation at the 25th Annual JPMorgan Healthcare Conference has...